Target Name: NXNL2
NCBI ID: G158046
Review Report on NXNL2 Target / Biomarker Content of Review Report on NXNL2 Target / Biomarker
NXNL2
Other Name(s): NXNL2_HUMAN | RdCVF2 | Nucleoredoxin-like protein 2 (isoform 2) | nucleoredoxin like 2 | RDCVF2 | Nucleoredoxin like 2 | Nucleoredoxin-like protein 2 | NXNL2 variant 2 | Rod-derived cone viability factor 2 | RdCVF2L | rod-derived cone viability factor 2 | C9orf121

Understanding NXNL2: Unraveling The Neurofilament Protein's Role in Brain Function

NXNL2 (NXNL2_HUMAN) is a protein that is expressed in various tissues of the human body, including the brain, heart, liver, and pancreas. It is a member of the neurofilament family, which is a group of proteins that are involved in the structure and function of the nervous system.

One of the key functions of NXNL2 is its role in the development and maintenance of neural circuits in the brain. NXNL2 is involved in the production and assembly of the neurotransmitter acetylcholine, which is a critical signaling molecule in the brain.

In addition to its role in neurotransmission, NXNL2 is also involved in the regulation of various cellular processes that are critical for brain function. For example, it is involved in the production and degradation of other proteins that are involved in the formation of blood-brain barrier, which is responsible for controlling the movement of substances into and out of the brain.

Despite its importance role in brain function, NXNL2 is not well understood. little is known about the specific functions of NXNL2, and there are limited studies that have been conducted to determine its potential as a drug target or biomarker.

One of the challenges in studying NXNL2 is its complex structure. NXNL2 is a member of the neurofilament family, which includes a variety of proteins with similar structural patterns. This makes it difficult to study the function of NXNL2 in isolation, and to determine how it interacts with other proteins.

Another challenge is the lack of experimental data on NXNL2. There are currently limited number of studies that have been conducted to determine the functions of NXNL2, and there is a lack of information on the properties of this protein.

Despite these challenges, researchers are actively working to study NXNL2 and its potential as a drug target or biomarker. One of the main goal of research is to understand the functions of NXNL2 and its potential role in the development and treatment of various neurological disorders.

In conclusion, NXNL2 is a protein that is expressed in various tissues of the human body, and it is involved in the development and maintenance of neural circuits in the brain. Despite its importance role in brain function, NXNL2 is not well understood, and there are limited studies that have been conducted to determine its potential as a drug target or biomarker. Further research is needed to understand the full potential of NXNL2 and its role in the treatment of various neurological disorders.

Protein Name: Nucleoredoxin Like 2

Functions: May be involved in the maintenance of both the function and the viability of sensory neurons, including photoreceptors and olfactory neurons

The "NXNL2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NXNL2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

NXPE1 | NXPE2 | NXPE3 | NXPE4 | NXPH1 | NXPH2 | NXPH3 | NXPH4 | NXT1 | NXT2 | NXTAR | NYAP1 | NYAP2 | NYNRIN | NYX | OACYLP | OAF | OARD1 | OAS1 | OAS2 | OAS3 | OASL | OAT | OATP1 | OAZ1 | OAZ2 | OAZ3 | OBI1 | OBI1-AS1 | OBP2A | OBP2B | OBSCN | OBSCN-AS1 | OBSL1 | OC90 | OCA2 | OCEL1 | OCIAD1 | OCIAD2 | OCLM | OCLN | OCLNP1 | OCM | OCM2 | OCRL | OCSTAMP | ODAD1 | ODAD2 | ODAD3 | ODAD4 | ODAM | ODAPH | ODC1 | ODCP | ODF1 | ODF2 | ODF2L | ODF3 | ODF3B | ODF3L1 | ODF3L2 | ODF4 | ODR4 | OFCC1 | OFD1 | OGA | OGDH | OGDHL | OGFOD1 | OGFOD2 | OGFOD3 | OGFR | OGFR-AS1 | OGFRL1 | OGFRP1 | OGG1 | OGN | OGT | OIP5 | OIP5-AS1 | OIT3 | OLA1 | OLA1P1 | OLAH | OLFM1 | OLFM2 | OLFM3 | OLFM4 | OLFML1 | OLFML2A | OLFML2B | OLFML3 | OLIG1 | OLIG2 | OLIG3 | Oligosaccharyltransferase complex | OLMALINC | OLR1 | OMA1 | OMD